Potent and selective inhibition of SH3 domains with dirhodium metalloinhibitors
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Abl SH3 domain preparation. The abl SH3 domain was amplified by PCR using Phusion DNA polymerase (Finnzymes). The reactions were performed following manufacture's protocol with Phusion HF buffer and 5% DMSO. Primers were designed as follows: 5'-GGATCCGAAAATGACCCCAACCTTTTCGTTG-3' (BamHI site underlined) and a reverse primer, 5'-GAATTCTTAACTGTTGACTGGCGTGATGTAGTTG-3' (EcoRI site underlined). The resultant product was digested with
BamHI and EcoRI and subcloned into BamHI-EcoRI sites of pGex-KTO. Confirmed PCR fidelity by sequencing.
Hck SH3 domain preparation. The hck SH3 domain was amplified by PCR using Phusion DNA polymerase (Finnzymes). The reactions were performed following manufacture's protocol with Phusion HF buffer and 5% DMSO. Primers were designed as follows: 5'-GGATCCGGCTCTGAGGACATCATCGTGGTTG-3' (BamHI site underlined) and a reverse primer, 5'-GAATTCTTACAGAGAGTCAACGCGGGCGACATAG-3' (EcoRI site underlined). The resultant product was digested with
Lyn SH3 domain preparation. The lyn SH3 domain was amplified by PCR using Phusion DNA polymerase (Finnzymes). The reactions were performed following manufacturer's protocol with Phusion HF buffer and 5% DMSO. Primers were designed as follows: 5'-GGATCCGAGGAACAAGGAGACATTGTGG-3' (BamHI site underlined) and a reverse primer, 5'-GAATTCTTAGAGTTTGGCCACATAGTTGCTG-3' (EcoRI site underlined). The resultant product was digested with BamHI and EcoRI and subcloned into BamHI-EcoRI sites of pGex-KTO. Confirmed PCR fidelity by sequencing.
Lyn SH3 mutagenesis. Single point mutations His17→Ala and His35→Ala; double mutation His17→Ala, His35→Ala of Lyn SH3 were performed using New England Biolabs Q5 mutagenesis kit. The pGex-KTO lyn SH3 construct was used as template.
The mutations were performed following manufacture's protocol. Primers were designed as follows: for H78A mutant: 5'-TGATGGCATCGCGCCGGACGACTTGTCTTTC-3' and a reverse primer, 5'-TAGGGGTACAAGGCTACC-3 (mutation site underlined); for H96A mutant: 5'-CCTGGAGGAGGCGGGAGAATGGTGGAAAG-3' and a reverse primer, 5'-ACTTTCATCTTCTCTCCTTTC-3' (mutation site underlined). The double mutant was prepared sequentially, using the same mutation primers. Confirmed PCR fidelity by sequencing.
After transformation of each plasmid into E. coli BL21 (DE3) the resulting cells were cultured under standard conditions.
Cells were grown at 37 °C to OD 600 of ~0.6 with 100 µg/mL ampicillin, at which point they were induced with 0.5 mM IPTG.
Cells were further incubated at 18 ˚C for 16 h before harvesting. Cells were pelleted by centrifugation at 10,000 g for 10 min.
The pellet was resuspended in 50 mM Tris (pH 7.5), 200 mM NaCl, 200-µg/mL lysozyme, 4 unit/mL DNase I, and 1 mM MgCl 2 and incubated on ice for 1 h., followed by sonication 4 × 30 s. Cellular debris was removed by centrifugation (17,000 g at 4 ˚C for 1 h). Supernatant was subjected to affinity column (Glutathione -agarose resin), washed with 10 column volumes of 20 mM
Tris and 200 mM NaCl at pH 7.5. Bound protein was eluted with 20 mM Tris, 200 mM NaCl, and 10 mM reduced glutathione at pH 7.5. The protein was concentrated and the buffer exchanged into cleavage buffer (200 mM Tris-HCl, 1.5 M NaCl, 25 mM CaCl 2 at pH 8.4) using Amicon Ultra centrifugal filters. The GST-tag was cleaved by incubation with thrombin (4 unit/mL) at 4 ˚C overnight.
The cleaved affinity tag was removed by size exclusion chromatography on a Superdex 75 column (GE Healthcare) equilibrated in 20 mM phosphate buffer containing 150 mM NaCl and 1 mM EDTA at pH 7. The purity of eluted fractions was assessed by SDS-PAGE using 12% Bis-Tris gels (Invitrogen). Fractions containing pure SH3 domain protein were pooled, concentrated, and aliquoted for storage at -80 ˚C. Concentration was determined using the absorbance at 280 nm (NanoDrop, Thermo Scientific).
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Computational Methods:
Four isomeric structures of Rh 2 OAc 4 bound to the Lyn-SH3 domain (1W1F PDB) were obtained by molecular mechanics (MM) geometry minimization using the UFF force field as implemented within Spartan '14. The atoms of Rh 2 OAc 4 and the rhodium-N His bonds were frozen during the calculation, allowing the protein to relax around the dirhodium center. The S2E peptide was subjected to a molecular dynamics simulation (Monte Carlo, parameters: T initial = 5000K and step size = 10 K) with Spartan '14, and the lowest energy conformation was added to the dirhodium center by substitution of the S2E glutamate side chain with that of an equatorial acetate ligand. QM/MM geometry optimization of the four resulting isomers was carried out using the ONIOM algorithm within Gaussian03 (G03). 8 Two layer ONIOM calculations were carried out in which the high and low layers were calculated using density functional theory (DFT) and MM, respectively. The molecular makeup of the high layer is illustrated in were present). 11 MM calculations used the UFF force field as implemented within G03, and charges were estimated at the initial geometry using the QEq algorithm. Geometry optimizations were carried out using the "quadmacro" option in order to produce finer optimization steps. All calculations minimized to geometries that exceeded the default optimization criteria, but subsequent analytical frequency calculations were not performed due to the size of the systems. The four minimized isomers are depicted in 
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Figure S15. Analytical FPLC spectra of Lck SH3 complex with increasing amounts of P12D Rh metallopeptide. * The binding isotherms for metallopeptide interactions with Hck were fitted using a two-sets-of-sites model with the stoichiometry for the second set of sites fixed to 2.0. The second set of binding sites was used to account for the weak, but not negligable, binding of the peptide to another surface of Hck SH3 domain, presumably through non-specific interactions of the dirhodium tetraacetate group. The thermodynamics for the high affinity specific binding site interaction are provided in this table.
Figure S16. Illustrations of QM/MM optimized geometries of Lyn-Rh S2E isomers with relative total energy and relevant structural metrics. Isomer labels reflect the coordinated nitrogen of the histidine residue with the first being that of His78 followed by His96 (below and above dirhodium, respectively). Figure S17 . Illustrations of QM/MM-optimized Lyn-Rh S2E isomers overlaid on the experimentally determined structure of Lyn-SH3 domain. Rh S2E and histidine protons have been removed from the illustration for clarity. Isomer colors correspond to those used in Figure S-1 . Visual inspection suggests that significant His78 displacement occurs for all isomers upon dirhodium binding whereas His96 displacement is largely minimized.
